Sign inJoin waitlistJoin the waitlist

JZ

Jesse Zaretsky

Physician · Washington University School of Medicine

Credentials: · · · · · ·

History

Washington University School of Medicine
2025–Present

Medical Oncology
2022–2024
Internal Medicine
2019–2022
David Geffen Sch of Med at UCLA
2015–2019

Research

Genetic basis for clinical response to CTLA-4 blockade in melanoma
New England Journal of Medicine · 2014 · 3,502 citations
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
New England Journal of Medicine · 2016 · First of 29 authors · 2,646 citations
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Cell Reports · 2017 · 1,523 citations

Antoni Ribas
19 papers
Siwen Hu-Lieskovan
10 papers · 10 as a resident
DS
Daniel Shin
6 papers
Douglas Adkins
6 papers
Sidharth Puram
6 papers
Bartosz Chmielowski
5 papers
Peter Oppelt
5 papers
Alex Harbison
4 papers
Anusha Kalbasi
4 papers · 1 as a resident
Jason Rich
4 papers
Jennifer Keihner
4 papers
Patrik Pipkorn
4 papers

Clinical trials

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2021–2027
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Sub-investigator · Not yet recruiting · Phase 1, Phase 2
Washington University School of Medicine
2026–2033
5-Fluorouracil Response and Optimization STudy (The FROST Trial)
Sub-investigator · Recruiting · Phase 2
Washington University School of Medicine
2026–2031
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Sub-investigator · Recruiting · Phase 2
Washington University School of Medicine
2025–2034